Inhibition of a Vesicular Stomatitis Virus Mutant by Rifampin
AUTOR(ES)
Moreau, Marie-Claude
RESUMO
Rifampin reversibly inhibits the intracellular replication of a VSV mutant, whereas a revertant variant selected from this viral population, as well as the wild strain, are not affected by this drug. Rifampin inhibits transcriptase activity of the sensitive mutant only and, consequently, total viral RNA synthesis decreases significantly in the cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=355545Documentos Relacionados
- Rifampin-susceptible mutant of vesicular stomatitis virus: protein and RNA synthesis.
- Inhibition of cellular DNA synthesis by vesicular stomatitis virus.
- Inhibition of vesicular stomatitis virus infection by nitric oxide.
- Inhibition of vesicular stomatitis virus RNA synthesis by protein hyperphosphorylation.
- Inhibition of cellular RNA synthesis by nonreplicating vesicular stomatitis virus.
